85 related articles for article (PubMed ID: 26703925)
1. Mast cell chymase in experimentally induced psoriasis.
Suttle MM; Harvima IT
J Dermatol; 2016 Jun; 43(6):693-6. PubMed ID: 26703925
[TBL] [Abstract][Full Text] [Related]
2. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M
Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961
[TBL] [Abstract][Full Text] [Related]
3. Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase.
Lipitsä T; Naukkarinen A; Laitala J; Harvima IT
Arch Dermatol Res; 2016 Oct; 308(8):575-84. PubMed ID: 27465068
[TBL] [Abstract][Full Text] [Related]
4. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
[TBL] [Abstract][Full Text] [Related]
5. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
Badertscher K; Brönnimann M; Karlen S; Braathen LR; Yawalkar N
Arch Dermatol Res; 2005 Apr; 296(10):503-6. PubMed ID: 15703960
[TBL] [Abstract][Full Text] [Related]
6. Decrease in chymase activity is associated with increase in IL-6 expression in mast cells in atopic dermatitis.
Ilves T; Harvima IT
Acta Derm Venereol; 2015 Apr; 95(4):411-6. PubMed ID: 25270893
[TBL] [Abstract][Full Text] [Related]
7. Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis.
Suttle MM; Enoksson M; Zoltowska A; Chatterjee M; Nilsson G; Harvima IT
Acta Derm Venereol; 2015 May; 95(5):536-41. PubMed ID: 25425229
[TBL] [Abstract][Full Text] [Related]
8. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
9. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
10. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.
Suttle MM; Nilsson G; Snellman E; Harvima IT
Clin Exp Immunol; 2012 Sep; 169(3):311-9. PubMed ID: 22861371
[TBL] [Abstract][Full Text] [Related]
11. Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
Reimer JM; Enoksson M; Samollow PB; Hellman L
Mol Immunol; 2008 Apr; 45(7):2116-25. PubMed ID: 18022236
[TBL] [Abstract][Full Text] [Related]
12. Mast cell chymase degrades fibrinogen and fibrin.
Lipitsä T; Siiskonen H; Naukkarinen A; Harvima IT
Br J Dermatol; 2019 Aug; 181(2):296-303. PubMed ID: 30561017
[TBL] [Abstract][Full Text] [Related]
13. Extended cleavage specificity of the mast cell chymase from the crab-eating macaque (Macaca fascicularis): an interesting animal model for the analysis of the function of the human mast cell chymase.
Thorpe M; Yu J; Boinapally V; Ahooghalandari P; Kervinen J; Garavilla Ld; Hellman L
Int Immunol; 2012 Dec; 24(12):771-82. PubMed ID: 22949566
[TBL] [Abstract][Full Text] [Related]
14. Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells--drastically reduced levels of tryptase and chymase in mast cell lines.
Guhl S; Babina M; Neou A; Zuberbier T; Artuc M
Exp Dermatol; 2010 Sep; 19(9):845-7. PubMed ID: 20545757
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
16. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
17. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of mucin secretion from human bronchial epithelial cells by mast cell chymase.
He SH; Zheng J
Acta Pharmacol Sin; 2004 Jun; 25(6):827-32. PubMed ID: 15169640
[TBL] [Abstract][Full Text] [Related]
19. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
Diaconu NC; Rummukainen J; Naukkarinen A; Mättö M; Harvima RJ; Pelkonen J; Harvima IT
Arch Dermatol Res; 2011 Sep; 303(7):499-512. PubMed ID: 21274549
[TBL] [Abstract][Full Text] [Related]
20. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
Li L; Meng XW; Krilis SA
J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
